Full Fed. Circ. Won't Rehear Fetal DNA Patent Row
The Federal Circuit on Wednesday denied a request to rehear en banc a decision that Sequenom Inc.'s patent for a fetal DNA test is patent-ineligible because it is directed to a...To view the full article, register now.
Already a subscriber? Click here to view full article